Myrbetriq and Pigmentation disorder - a phase IV clinical study of FDA data

Summary:

Pigmentation disorder is reported as a side effect among people who take Myrbetriq (mirabegron), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Nexium, and have Hypertonic bladder.

The phase IV clinical study analyzes which people have Pigmentation disorder when taking Myrbetriq. It is created by eHealthMe based on reports of 33,382 people who have side effects when taking Myrbetriq from the FDA, and is updated regularly.

What is Myrbetriq?

Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 33,658 Myrbetriq users. Check the latest studies of Myrbetriq.

What is Pigmentation disorder?

Pigmentation disorder (disturbances of human skin colour) is found to be associated with 642 drugs and 771 conditions by eHealthMe. Check the latest studies of Pigmentation disorder.

On Jul, 09, 2026

33,382 people reported to have side effects when taking Myrbetriq.
Among them, 12 people (0.04%) have Pigmentation disorder.

Could Myrbetriq cause Pigmentation disorder?

Among these 12 people:

How long have people been on Myrbetriq when they have Pigmentation disorder? *

What is the gender of people who have Pigmentation disorder when taking Myrbetriq? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Pigmentation disorder when taking Myrbetriq? *

What are other drugs people take besides Myrbetriq? *

What are other side effects people have besides Pigmentation disorder? *

Constipation: 4 people, 33.33%
Rashes (redness): 3 people, 25.00%
Diarrhea: 3 people, 25.00%
Dry Skin: 3 people, 25.00%
Skin Discoloration: 3 people, 25.00%
Headache (pain in head): 3 people, 25.00%
Dizziness: 3 people, 25.00%
Fever: 2 people, 16.67%
Gait Disturbance: 2 people, 16.67%
Gastric Ulcer (stomach ulcer): 2 people, 16.67%

What are the existing conditions these people have? *

Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 25.00%
Thyroid Diseases: 2 people, 16.67%
Stress And Anxiety: 2 people, 16.67%
Sleep Disorder: 2 people, 16.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 16.67%
Muscle Spasms (muscle contraction): 2 people, 16.67%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 2 people, 16.67%
Lymphoma (cancer that begins in immune system cells): 2 people, 16.67%
Joint Pain: 2 people, 16.67%
High Blood Cholesterol: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Myrbetriq and have Pigmentation disorder?

- Check whether Pigmentation disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Myrbetriq:

Myrbetriq (33,658 reports)

Browse all side effects of Myrbetriq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pigmentation disorder:

Pigmentation disorder (642 drugs)

Browse all the conditions that are associated with Pigmentation disorder:

Pigmentation disorder (771 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Myrbetriq) and Myrbetriq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.